UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002477
Receipt number R000003036
Scientific Title Drug-drug interaction study to explore importance of CYP3A4 and OATP1B1 as factors determining pharmacokinetics of atorvastatin
Date of disclosure of the study information 2009/09/10
Last modified on 2012/07/13 14:16:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Drug-drug interaction study to explore
importance of CYP3A4 and OATP1B1 as factors determining pharmacokinetics of atorvastatin

Acronym

Drug-drug interaction study on atorvastatin

Scientific Title

Drug-drug interaction study to explore
importance of CYP3A4 and OATP1B1 as factors determining pharmacokinetics of atorvastatin

Scientific Title:Acronym

Drug-drug interaction study on atorvastatin

Region

Japan


Condition

Condition

healthy male subjects

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To examine the effects of functional variation of OATP1B1and CYP3A4 on pharmacokinetics of atorvastatin in japanese healthy subjects by using microdose.

Basic objectives2

Others

Basic objectives -Others

gene analysis

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

pharmacokinetic of atorvastatin

Key secondary outcomes

pharmacokinetics of midazolam, pravastatin, itraconazole and rifampicin
gene analysis


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Drug administration(microdose of atorvastatin,midazolam,pravastatin)->(over 1week for washout)->Drug administration(clinical dose of rifampicin,microdose of atorvastatin, midazolam,pravastatin)->(over 1week for washout)->Drug administration(clinical dose of itraconazole,microdose of atorvasutatin, midazolam, pravastatin)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >

Gender

Male

Key inclusion criteria

1)Ability to understand and willing to sign the informed consent.
2)Japanese healthy male subjects age 20 to 40 years of age
3)Weight between 50-100kg.
4)Healthy subject as determined by medical history, physical examination, ECGs, and clinical laboratory tests.

Key exclusion criteria

1)Any hypersensitivities to atorvastatin,midazolam,pravastatin, straconazole or rifampicin.
2)hepatic disease requiring treatment.
3)acute narrow-angle glaucoma
4)QT prolongation over 460ms.
5)Use of medicine or health product including Saint John's wort 2 weeks before pre-dose.
6)Intake of fruit food and drink including grapefruit juice, orange juice or apple juice from 7 days before pre-dose.
7)Participation to any other clinical reseach in the past 3 months.
8)Donating over 200 ml of blood in the past 1 month or over 400ml of blood in the past 3 months.
9)Positive tests of serological reaction for syphilis, HIV antigen and antibody, HBs antigen or HCV antibody.
10)Any allergy to drug and food
11)Drug abuse or positive drug screening
12)Any condition that, in the opinion of the investigator, would make the patient unsuitable for the study.

Target sample size

8


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuji Kumagai

Organization

Kitsato University East Hospital

Division name

Clinical trial Center

Zip code


Address

2-1-1, Asamizodai, Sagamihara, Kanagawa, 228-8520

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kitsato University East Hospital

Division name

Clinical trial Center

Zip code


Address

2-1-1, Asamizodai, Sagamihara, Kanagawa, 228-8520

TEL


Homepage URL


Email



Sponsor or person

Institute

Clinical trial Center,Kitsato University East Hospital

Institute

Department

Personal name



Funding Source

Organization

APDD, Association for Promoting Drug Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 09 Month 10 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 08 Month 30 Day

Date of IRB


Anticipated trial start date

2009 Year 09 Month 01 Day

Last follow-up date

2009 Year 11 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 09 Month 10 Day

Last modified on

2012 Year 07 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003036


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name